NFKB1 and colitis: We report for the first time that BMDA and its derivative, DMMA, exert anti-inflammatory effects on DNBS-induced colitis and collagen-induced RA disease, which could be attributed to the downregulation of p38MAPK-MK2 inflammation and suppression of the NF-κB signaling pathway.